New Jersey Senate Bill S2808

New Jersey 2022-2023 Regular Session

• Introduced: 6/9/22
• Refer: 6/9/22

Caption

Establishes Statewide Opioid Antidote Coordinator position; appropriates funds.

Impact

The creation of the Statewide Opioid Antidote Coordinator is expected to significantly streamline the process of procuring and distributing opioid antidotes across New Jersey. By centralizing this responsibility, the bill aims to facilitate access for emergency medical services, law enforcement, schools, and other entities that may need to administer opioid antidotes. Moreover, the coordinator will be tasked with liaising with other government agencies to ensure effective collaboration in combating the opioid epidemic. The bill also mandates the development of a public-facing website that will provide important information regarding opioid antidotes, including their administration and access points, which could enhance public awareness and responsiveness.

Summary

Senate Bill S2808 establishes the position of the Statewide Opioid Antidote Coordinator within the New Jersey Department of Human Services. This role is specifically designed to oversee the bulk purchasing and distribution of opioid antidotes, such as naloxone, on behalf of various governmental and health entities. The coordinator will serve at the will of the Commissioner of Human Services, who must ensure that the appointee possesses relevant experience in fields such as mental health, law enforcement, and health policy. This legislation is aimed at enhancing the State's response to the opioid crisis by providing a structured approach to acquiring and distributing these vital lifesaving drugs.

Contention

One notable area of contention regarding S2808 may revolve around funding and the long-term efficacy of the proposed office. While the bill outlines that the office will seek federal funds and annual appropriations, concerns may arise regarding the sustainability of this funding model and whether it will be sufficient to meet the demand for opioid antidotes. Additionally, there may be discussions on how this new centralized authority could impact existing local initiatives aimed at addressing opioid-related issues.